ACVC Partners

Elegen is a biotechnology company founded in 2017 and led by Dr. Matthew Hill, specializing in the development of microfluidic technology. The company focuses on creating innovative DNA synthesizers that enhance the engineering of entire genomes. By leveraging its advanced technology, Elegen aims to accelerate biomedical advancements and facilitate DNA sequence testing within the healthcare industry. Through its commitment to disrupting synthetic biology, Elegen is positioned to play a pivotal role in the future of genetic research and applications.

EnCharge AI is a developer of advanced artificial intelligence hardware and software systems specifically designed for edge computing. The company provides a robust computing platform that enhances AI performance by enabling larger models, improved accuracy, higher resolutions, and support for multiple camera channels. With a focus on scalable AI architectures and flexible software integration, EnCharge AI's technology allows businesses to efficiently access and implement advanced AI capabilities without the need for time-consuming and costly workarounds. The company's innovations are rooted in extensive research and development, positioning it as a leader in the AI hardware and software landscape.

Helm.ai, founded in 2016 and based in Redwood City, California, specializes in developing advanced AI software solutions for Advanced Driver Assistance Systems (ADAS), autonomous driving, and robotics automation. The company focuses on creating full-stack real-time AI systems, including deep neural networks for both highway and urban driving scenarios, as well as end-to-end autonomous systems. Helm.ai's technology leverages unsupervised learning to train neural networks without requiring extensive fleet data or simulation, making it a key player in the development of safe and scalable autonomous technologies. The company collaborates with global automakers on production-bound projects.

Debut Biotechnology, Inc. is a biotechnology company based in San Diego, California, established in 2019. It specializes in biomanufacturing solutions for high-value molecules, focusing on the development of specialty enzyme solutions and continuous manufacturing processes. The company offers a range of services, including biomanufacturing cartridges, fermentation, and the immobilization of cells and enzymes. Debut Biotechnology is dedicated to creating novel immobilization techniques for enzymes, achieving high success rates and providing immobilized enzymes for continuous manufacturing systems. Its innovative approach enables the production and modification of small and large molecules, catering primarily to the pharmaceutical and specialty chemical industries. By harnessing natural enzyme technologies, Debut aims to deliver sustainable and cost-effective ingredient solutions to its clients.

Helm.ai, founded in 2016 and based in Redwood City, California, specializes in developing advanced AI software solutions for Advanced Driver Assistance Systems (ADAS), autonomous driving, and robotics automation. The company focuses on creating full-stack real-time AI systems, including deep neural networks for both highway and urban driving scenarios, as well as end-to-end autonomous systems. Helm.ai's technology leverages unsupervised learning to train neural networks without requiring extensive fleet data or simulation, making it a key player in the development of safe and scalable autonomous technologies. The company collaborates with global automakers on production-bound projects.

Boston Materials, Inc. is a manufacturer of advanced composite materials based in Bedford, Massachusetts, founded in 2016. The company specializes in producing 3D reinforced carbon fiber pre-pregs and offers a patented Z-axis Fiber technology that incorporates vertically aligned carbon fibers. This innovative approach enhances the thermal, electrical, and mechanical properties of materials, making them suitable for various high-growth industries, including semiconductors, aerospace, automotive, and renewable energy. Boston Materials' products are designed to improve performance, efficiency, and reliability while addressing challenges related to durability and weight reduction. The company employs a roll-to-roll manufacturing process with in-line quality control, achieving an annual production capacity of one million square meters.

Sepion Technologies is an advanced membrane company based in Emeryville, California, founded in 2015. It specializes in the development of highly-tunable nanoscale membranes designed for various industrial applications, particularly in the energy storage sector. The company focuses on manufacturing innovative lithium-metal batteries by integrating nanoscience, polymer chemistry, and cell engineering. Its proprietary composite membrane serves as a cost-effective alternative to traditional ceramic separators used in lithium batteries, allowing for large-area production. This technology enables battery manufacturers to enhance energy density in their products, thereby improving overall performance and efficiency in energy storage solutions.

Debut Biotechnology, Inc. is a biotechnology company based in San Diego, California, established in 2019. It specializes in biomanufacturing solutions for high-value molecules, focusing on the development of specialty enzyme solutions and continuous manufacturing processes. The company offers a range of services, including biomanufacturing cartridges, fermentation, and the immobilization of cells and enzymes. Debut Biotechnology is dedicated to creating novel immobilization techniques for enzymes, achieving high success rates and providing immobilized enzymes for continuous manufacturing systems. Its innovative approach enables the production and modification of small and large molecules, catering primarily to the pharmaceutical and specialty chemical industries. By harnessing natural enzyme technologies, Debut aims to deliver sustainable and cost-effective ingredient solutions to its clients.

Boston Materials, Inc. is a manufacturer of advanced composite materials based in Bedford, Massachusetts, founded in 2016. The company specializes in producing 3D reinforced carbon fiber pre-pregs and offers a patented Z-axis Fiber technology that incorporates vertically aligned carbon fibers. This innovative approach enhances the thermal, electrical, and mechanical properties of materials, making them suitable for various high-growth industries, including semiconductors, aerospace, automotive, and renewable energy. Boston Materials' products are designed to improve performance, efficiency, and reliability while addressing challenges related to durability and weight reduction. The company employs a roll-to-roll manufacturing process with in-line quality control, achieving an annual production capacity of one million square meters.

DarwinAI Corp. is a Canadian company that specializes in artificial intelligence technology, particularly in the development of deep neural networks for enterprise applications. Founded in 2017 and based in Waterloo, the company offers GenSynth, a software platform designed for developers and data scientists to streamline the deep learning development process. GenSynth employs generative synthesis technology, allowing for the automatic creation of optimized, explainable AI models that meet specific performance criteria while ensuring transparency throughout the development stages. Additionally, DarwinAI has developed an AI-powered visual quality inspection system aimed at enhancing the PCBA manufacturing lifecycle. This system leverages specialized optics and advanced algorithms to detect defects in products, improving quality and consistency while reducing costs for manufacturers.

Medable, Inc. is a technology company that operates a medical-grade Platform-as-a-Service, designed to facilitate the development of compliant applications and services for the healthcare sector. The platform enables healthcare professionals, hospitals, and medical device manufacturers to create mobile and web applications that support clinical trials while adhering to health privacy regulations. Medable's offerings include solutions for telemedicine, allowing for HIPAA-compliant video consultations and capturing clinical trial outcomes remotely. The platform enhances the efficiency of clinical trials by streamlining design, recruitment, retention, and data quality, thereby improving patient access, experience, and outcomes. Founded in 2015 and headquartered in Palo Alto, California, Medable's solutions are utilized by leading biopharmaceutical companies and clinical research organizations across more than 30 countries and in 26 languages.